[Progress of immune system indices in the treatment of chronic inflammatory diseases of the biliary duct].
In 105 patients with chronic inflammatory illness of gallbladder and biliary ducts the generally-accepted therapy have influenced the IgM and IgG contents in serum, the lymphocytes sensibilization to the tissue antigens of gallbladder, liver, pancreas, the titre of antibodies to this antigens only. The authors insist on necessity of supplementary application of immunomodulating agents in the complex of patients treatment, especially if reactive hepatitis or pancreatitis is present.
Sherstiuk
P Ia
PIa
Epishin
A V
AV
Khabarova
N A
NA
Starodub
E M
EM
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology*; D001660:Biliary Tract Diseases / Q000188:drug therapy* / Q000276:immunology*; D002764:Cholecystitis / Q000188:drug therapy* / Q000276:immunology*; D002908:Chronic Disease; D004653:Empyema / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D007075:Immunoglobulin M / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology*
D000276:Adjuvants, Immunologic; D007074:Immunoglobulin G; D007075:Immunoglobulin M
Dynamika poraznykiv imunnoï systemy pry likuvanni khronichnykh zapal'nykh zakhvoriuvan' biliarnoï systemy.